BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38714079)

  • 1. Photothermal and ferroptosis synergistic therapy for liver cancer using iron-doped polydopamine nanozymes.
    Li Y; Qian L; Yang Z; Li S; Wu A; Wang X
    Colloids Surf B Biointerfaces; 2024 Jul; 239():113911. PubMed ID: 38714079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photothermal nanozymes to self-augment combination cancer therapy by dual-glutathione depletion and hyperthermia/acidity-activated hydroxyl radical generation.
    Wang TH; Shen MY; Yeh NT; Chen YH; Hsu TC; Chin HY; Wu YT; Tzang BS; Chiang WH
    J Colloid Interface Sci; 2023 Nov; 650(Pt B):1698-1714. PubMed ID: 37499626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor microenvironment-responsive polydopamine-based core/shell nanoplatform for synergetic theranostics.
    Chen Q; Shan X; Shi S; Jiang C; Li T; Wei S; Zhang X; Sun G; Liu J
    J Mater Chem B; 2020 May; 8(18):4056-4066. PubMed ID: 32270145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degradable iron-rich mesoporous dopamine as a dual-glutathione depletion nanoplatform for photothermal-enhanced ferroptosis and chemodynamic therapy.
    Cheng H; He Y; Lu J; Yan Z; Song L; Mao Y; Di D; Gao Y; Zhao Q; Wang S
    J Colloid Interface Sci; 2023 Jun; 639():249-262. PubMed ID: 36805750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vitro Synergistic Photodynamic, Photothermal, Chemodynamic, and Starvation Therapy Performance of Chlorin e6 Immobilized, Polydopamine-Coated Hollow, Porous Ceria-Based, Hypoxia-Tolerant Nanozymes Carrying a Cascade System.
    Süngü Akdogan ÇZ; Akbay Çetin E; Onur MA; Önel S; Tuncel A
    ACS Appl Bio Mater; 2024 May; 7(5):2781-2793. PubMed ID: 38380497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondria-Targeting MoS
    Li X; Xiao H; Xiu W; Yang K; Zhang Y; Yuwen L; Yang D; Weng L; Wang L
    ACS Appl Mater Interfaces; 2021 Dec; 13(47):55928-55938. PubMed ID: 34786942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Based on polydopamine-coated metal organic framework multifunctional nanoplatform for enhanced photothermal/sonodynamicand treatment combined with checkpoint blockade therapy.
    Bai Z; Huang J; Lu H; Wang N; Li H; Zhu Y
    Int J Biol Macromol; 2024 Jun; 269(Pt 2):132207. PubMed ID: 38723823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chlorin e6 and polydopamine modified gold nanoflowers for combined photothermal and photodynamic therapy.
    Wu F; Liu Y; Wu Y; Song D; Qian J; Zhu B
    J Mater Chem B; 2020 Mar; 8(10):2128-2138. PubMed ID: 32073096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine-Modified Zero-Valent Iron Nanoparticles for Dual-Modality Photothermal and Photodynamic Breast Cancer Therapy.
    Yu HH; Lin CH; Chen YC; Chen HH; Lin YJ; Lin KA
    ChemMedChem; 2020 Sep; 15(17):1645-1651. PubMed ID: 32338431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Manganese-containing polydopamine nanoparticles as theranostic agents for magnetic resonance imaging and photothermal/chemodynamic combined ferroptosis therapy treating gastric cancer.
    Chen Z; Li Z; Li C; Huang H; Ren Y; Li Z; Hu Y; Guo W
    Drug Deliv; 2022 Dec; 29(1):1201-1211. PubMed ID: 35403518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linker-free Gold Nanoparticle Superstructure Coated with Poly(dopamine) by Site-Specific Polymerization for Amplifying Photothermal Cancer Therapy.
    Pan LL; Yang Y; Li DL; Geng WC; Jiang ZL; Song GS; Li YJ
    Chem Asian J; 2020 Sep; 15(17):2742-2748. PubMed ID: 32658379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutual Benefit between Cu(II) and Polydopamine for Improving Photothermal-Chemodynamic Therapy.
    Zhang WX; Hao YN; Gao YR; Shu Y; Wang JH
    ACS Appl Mater Interfaces; 2021 Aug; 13(32):38127-38137. PubMed ID: 34347422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced photothermal-ferroptosis effects based on RBCm-coated PDA nanoparticles for effective cancer therapy.
    Yu H; Yan J; Li Z; Song T; Ning F; Tan J; Sun Y
    J Mater Chem B; 2023 Jan; 11(2):415-429. PubMed ID: 36512437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemodynamic and Photothermal Combination Therapy Based on Dual-Modified Metal-Organic Framework for Inducing Tumor Ferroptosis/Pyroptosis.
    Deng H; Zhang J; Yang Y; Yang J; Wei Y; Ma S; Shen Q
    ACS Appl Mater Interfaces; 2022 Jun; 14(21):24089-24101. PubMed ID: 35588091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. H
    Xiao Z; Zuo W; Chen L; Wu L; Liu N; Liu J; Jin Q; Zhao Y; Zhu X
    ACS Appl Mater Interfaces; 2021 Sep; 13(37):43925-43936. PubMed ID: 34499485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tailored-Made Polydopamine Nanoparticles to Induce Ferroptosis in Breast Cancer Cells in Combination with Chemotherapy.
    Nieto C; Vega MA; Martín Del Valle EM
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33808898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. pH-Responsive Sorafenib/Iron-Co-Loaded Mesoporous Polydopamine Nanoparticles for Synergistic Ferroptosis and Photothermal Therapy.
    Liu S; Liu Y; Chang Q; Celia C; Deng X; Xie Y
    Biomacromolecules; 2024 Jan; 25(1):522-531. PubMed ID: 38087829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose-responsive enzymatic biomimetic nanodots for H
    Xu Y; Bian J; Liu X; Qian Z; Sun M; Zhang C; Pan R; Li Q; Sun C; Lin B; Peng K; Lu N; Yao X; Fan W
    Acta Biomater; 2023 Dec; 172():441-453. PubMed ID: 37802309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multifunctional cascade nanoreactor based on Fe-driven carbon nanozymes for synergistic photothermal/chemodynamic antibacterial therapy.
    Shen Y; Nie C; Pan T; Zhang W; Yang H; Ye Y; Wang X
    Acta Biomater; 2023 Sep; 168():580-592. PubMed ID: 37451659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasmall Zwitterionic Polypeptide-Coordinated Nanohybrids for Highly Efficient Cancer Photothermal Ferrotherapy.
    Du C; Zhou L; Qian J; He M; Zhang ZG; Feng C; Zhang Y; Zhang R; Dong CM
    ACS Appl Mater Interfaces; 2021 Sep; 13(37):44002-44012. PubMed ID: 34494817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.